US Patent 10980922 Hemostatic devices and methods of use
Patent 10980922 was granted and assigned to Medtronic on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+319 characters)
Article
Patent abstract
An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Charlie Wood0
Fatima Buevich0
Franklin R. Mansfield0
Jorge Alberto Trevino Blanco0
Jorie S. Soskin0
Kai R. Worrell0
Narvel M. Brooks, III0
Satish Pulapura0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10980922 Hemostatic devices and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10980922
Date of patent
April 20, 2021
Patent application number
15583086
Date Filed
May 1, 2017
Patent primary examiner
Find more entities like US Patent 10980922 Hemostatic devices and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
